Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,662 | 136 | 65.9% |
| Consulting Fee | $1,300 | 2 | 32.2% |
| Education | $76.40 | 6 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,300 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $419.65 | 27 | $0 (2024) |
| ABBVIE INC. | $319.91 | 16 | $0 (2024) |
| Intuitive Surgical, Inc. | $220.17 | 5 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $199.74 | 9 | $0 (2024) |
| CONMED Corporation | $163.42 | 3 | $0 (2022) |
| Daiichi Sankyo Inc. | $143.90 | 8 | $0 (2024) |
| Amgen Inc. | $126.55 | 9 | $0 (2019) |
| Teleflex LLC | $107.34 | 2 | $0 (2021) |
| CooperSurgical, Inc. | $100.72 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $390.85 | 20 | Sumitomo Pharma America, Inc. ($129.92) |
| 2023 | $1,832 | 29 | Applied Medical Resources Corporation ($1,300) |
| 2022 | $210.77 | 7 | CONMED Corporation ($108.90) |
| 2021 | $194.59 | 2 | CooperSurgical, Inc. ($100.72) |
| 2020 | $118.56 | 9 | AbbVie Inc. ($50.54) |
| 2019 | $515.86 | 30 | AbbVie, Inc. ($165.94) |
| 2018 | $486.59 | 32 | Amgen Inc. ($87.43) |
| 2017 | $288.88 | 15 | Astellas Pharma US Inc ($106.05) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Urology | ||||||
| 11/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Biological | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: HORMONE THERAPY | ||||||
| 10/18/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: VACCINES | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Biological | ||||||
| 09/12/2024 | Axonics, Inc. | Bulkamid (Device), Axonics | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Urology | ||||||
| 08/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Biological | ||||||
| 07/23/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: ETONOGESTREL | ||||||
| 07/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Biological | ||||||
| 05/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Endocrinology | ||||||
| 05/13/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: HORMONE THERAPY | ||||||
| 04/19/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/09/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: HORMONE THERAPY | ||||||
| 04/03/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Education | In-kind items and services | $19.27 | General |
| Category: HORMONE THERAPY | ||||||
| 04/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Biological | ||||||
| 03/07/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: ETONOGESTREL | ||||||
| 02/01/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: HORMONE THERAPY | ||||||
| 01/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Biological | ||||||
| 01/03/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: HORMONE THERAPY | ||||||
| 11/27/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Biological | ||||||
| 11/17/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/06/2023 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: VACCINES | ||||||
| 10/23/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Biological | ||||||
| 10/19/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.57 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 145 | 152 | $16,307 | $6,596 |
| 2022 | 4 | 117 | 123 | $13,495 | $6,007 |
| 2021 | 6 | 170 | 243 | $24,068 | $9,549 |
| 2020 | 5 | 106 | 224 | $22,885 | $8,170 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 53 | 53 | $4,240 | $2,134 | 50.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 57 | 57 | $4,275 | $2,068 | 48.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 25 | $3,372 | $1,221 | 36.2% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 17 | 17 | $4,420 | $1,172 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 26 | $3,250 | $1,608 | 49.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 43 | 43 | $3,225 | $1,570 | 48.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 39 | 39 | $3,120 | $1,567 | 50.2% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 15 | 15 | $3,900 | $1,262 | 32.4% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 32 | 35 | $9,100 | $2,840 | 31.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 49 | 49 | $3,920 | $1,987 | 50.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 53 | 53 | $3,975 | $1,950 | 49.1% |
| 97530 | Therapeutic activities to improve function, with one-on-one contact between patient and provider, each 15 minutes | Office | 2021 | 11 | 49 | $2,695 | $1,128 | 41.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 16 | $2,000 | $959.74 | 48.0% |
| 97110 | Therapeutic exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2021 | 12 | 41 | $2,378 | $684.23 | 28.8% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 45 | 50 | $13,000 | $3,887 | 29.9% |
| 97140 | Manual (physical) therapy techniques to 1 or more regions, each 15 minutes | Office | 2020 | 11 | 95 | $4,750 | $1,671 | 35.2% |
| 97530 | Therapeutic activities to improve function, with one-on-one contact between patient and provider, each 15 minutes | Office | 2020 | 11 | 40 | $2,200 | $1,093 | 49.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 21 | 21 | $1,515 | $788.19 | 52.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 18 | 18 | $1,420 | $731.12 | 51.5% |
About Dr. Chad Drey, MD
Dr. Chad Drey, MD is a Obstetrics & Gynecology healthcare provider based in Johnson City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518096742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chad Drey, MD has received a total of $4,039 in payments from pharmaceutical and medical device companies, with $390.85 received in 2024. These payments were reported across 144 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($2,662).
As a Medicare-enrolled provider, Drey has provided services to 538 Medicare beneficiaries, totaling 742 services with total Medicare billing of $30,322. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Johnson City, TN
- Active Since 03/05/2007
- Last Updated 02/14/2025
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1518096742
Products in Payments
- Da Vinci Surgical System (Device) $220.17
- MYFEMBREE (Drug) $217.14
- Veozah (Drug) $186.86
- Orilissa (Drug) $165.94
- Myrbetriq (Drug) $150.16
- INJECTAFER (Drug) $143.90
- AIRSEAL (Device) $108.90
- Prolia (Biological) $101.20
- Obstetrical Products (Device) $100.72
- Percutaneous: MiniLap System with ThumbGrip Handle (Device) $93.87
- LO LOESTRIN FE (Drug) $82.62
- NEXPLANON (Drug) $81.93
- Balcoltra (Drug) $71.36
- INTRAROSA (Drug) $56.04
- ORILISSA (Drug) $49.58
- UBRELVY (Drug) $49.43
- MYRBETRIQ (Drug) $49.00
- Kyleena (Drug) $45.43
- Trulance (Drug) $39.64
- BOOSTRIX (Biological) $36.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Johnson City
Grover May, M.d, M.D
Obstetrics & Gynecology — Payments: $871,502
Dr. Erin Miller, D.o, D.O
Obstetrics & Gynecology — Payments: $58,295
Alison Sullivan, Do, DO
Obstetrics & Gynecology — Payments: $3,079
Samuel Lewis, M.d, M.D
Obstetrics & Gynecology — Payments: $2,659
Hasmik Stepanyan, Md, MD
Obstetrics & Gynecology — Payments: $2,358
Jill Talley-Horne, M.d, M.D
Obstetrics & Gynecology — Payments: $2,113